Insulin Lispro - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB504240585

Publication Date:

April 3, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of the insulin polypeptide.
The global market for Insulin Lispro was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
In India, Insulin Lispro key players include Eli Lilly and Company, Gan & Lee Pharmaceuticals, etc. India top two manufacturers hold a share about 100%.
In terms of product, Mixed insulin aspart is the largest segment of Cobalt, with a share about 55%. And in terms of application, the largest application is Type 2 Diabetes, followed by Type 1 Diabetes.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Lispro, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Lispro by region & country, by Type, and by Application.
The Insulin Lispro market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Lispro.
Market Segmentation
By Company
Eli Lilly and Company
Gan & Lee Pharmaceuticals
Segment by Type:
Insulin aspart
Mixed insulin aspart
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insulin Lispro manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insulin Lispro in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insulin Lispro in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Insulin Lispro Product Introduction
1.2 Global Insulin Lispro Market Size Forecast
1.2.1 Global Insulin Lispro Sales Value (2019-2030)
1.2.2 Global Insulin Lispro Sales Volume (2019-2030)
1.2.3 Global Insulin Lispro Sales Price (2019-2030)
1.3 Insulin Lispro Market Trends & Drivers
1.3.1 Insulin Lispro Industry Trends
1.3.2 Insulin Lispro Market Drivers & Opportunity
1.3.3 Insulin Lispro Market Challenges
1.3.4 Insulin Lispro Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insulin Lispro Players Revenue Ranking (2023)
2.2 Global Insulin Lispro Revenue by Company (2019-2024)
2.3 Global Insulin Lispro Players Sales Volume Ranking (2023)
2.4 Global Insulin Lispro Sales Volume by Company Players (2019-2024)
2.5 Global Insulin Lispro Average Price by Company (2019-2024)
2.6 Key Manufacturers Insulin Lispro Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Insulin Lispro Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Insulin Lispro
2.9 Insulin Lispro Market Competitive Analysis
2.9.1 Insulin Lispro Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Lispro Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Lispro as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Insulin aspart
3.1.2 Mixed insulin aspart
3.2 Global Insulin Lispro Sales Value by Type
3.2.1 Global Insulin Lispro Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Insulin Lispro Sales Value, by Type (2019-2030)
3.2.3 Global Insulin Lispro Sales Value, by Type (%) (2019-2030)
3.3 Global Insulin Lispro Sales Volume by Type
3.3.1 Global Insulin Lispro Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Insulin Lispro Sales Volume, by Type (2019-2030)
3.3.3 Global Insulin Lispro Sales Volume, by Type (%) (2019-2030)
3.4 Global Insulin Lispro Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Type 1 Diabetes
4.1.2 Type 2 Diabetes
4.2 Global Insulin Lispro Sales Value by Application
4.2.1 Global Insulin Lispro Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Insulin Lispro Sales Value, by Application (2019-2030)
4.2.3 Global Insulin Lispro Sales Value, by Application (%) (2019-2030)
4.3 Global Insulin Lispro Sales Volume by Application
4.3.1 Global Insulin Lispro Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Insulin Lispro Sales Volume, by Application (2019-2030)
4.3.3 Global Insulin Lispro Sales Volume, by Application (%) (2019-2030)
4.4 Global Insulin Lispro Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Insulin Lispro Sales Value by Region
5.1.1 Global Insulin Lispro Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Insulin Lispro Sales Value by Region (2019-2024)
5.1.3 Global Insulin Lispro Sales Value by Region (2025-2030)
5.1.4 Global Insulin Lispro Sales Value by Region (%), (2019-2030)
5.2 Global Insulin Lispro Sales Volume by Region
5.2.1 Global Insulin Lispro Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Insulin Lispro Sales Volume by Region (2019-2024)
5.2.3 Global Insulin Lispro Sales Volume by Region (2025-2030)
5.2.4 Global Insulin Lispro Sales Volume by Region (%), (2019-2030)
5.3 Global Insulin Lispro Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Insulin Lispro Sales Value, 2019-2030
5.4.2 North America Insulin Lispro Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Insulin Lispro Sales Value, 2019-2030
5.5.2 Europe Insulin Lispro Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Insulin Lispro Sales Value, 2019-2030
5.6.2 Asia Pacific Insulin Lispro Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Insulin Lispro Sales Value, 2019-2030
5.7.2 South America Insulin Lispro Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insulin Lispro Sales Value, 2019-2030
5.8.2 Middle East & Africa Insulin Lispro Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insulin Lispro Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Insulin Lispro Sales Value
6.2.1 Key Countries/Regions Insulin Lispro Sales Value, 2019-2030
6.2.2 Key Countries/Regions Insulin Lispro Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Insulin Lispro Sales Value, 2019-2030
6.3.2 United States Insulin Lispro Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Insulin Lispro Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Insulin Lispro Sales Value, 2019-2030
6.4.2 Europe Insulin Lispro Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Insulin Lispro Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Insulin Lispro Sales Value, 2019-2030
6.5.2 China Insulin Lispro Sales Value by Type (%), 2023 VS 2030
6.5.3 China Insulin Lispro Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Insulin Lispro Sales Value, 2019-2030
6.6.2 Japan Insulin Lispro Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Insulin Lispro Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Insulin Lispro Sales Value, 2019-2030
6.7.2 South Korea Insulin Lispro Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Insulin Lispro Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Insulin Lispro Sales Value, 2019-2030
6.8.2 Southeast Asia Insulin Lispro Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Insulin Lispro Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Insulin Lispro Sales Value, 2019-2030
6.9.2 India Insulin Lispro Sales Value by Type (%), 2023 VS 2030
6.9.3 India Insulin Lispro Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Company Information
7.1.2 Eli Lilly and Company Introduction and Business Overview
7.1.3 Eli Lilly and Company Insulin Lispro Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Eli Lilly and Company Insulin Lispro Product Offerings
7.1.5 Eli Lilly and Company Recent Development
7.2 Gan & Lee Pharmaceuticals
7.2.1 Gan & Lee Pharmaceuticals Company Information
7.2.2 Gan & Lee Pharmaceuticals Introduction and Business Overview
7.2.3 Gan & Lee Pharmaceuticals Insulin Lispro Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Gan & Lee Pharmaceuticals Insulin Lispro Product Offerings
7.2.5 Gan & Lee Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Insulin Lispro Industrial Chain
8.2 Insulin Lispro Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insulin Lispro Sales Model
8.5.2 Sales Channel
8.5.3 Insulin Lispro Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Eli Lilly and Company
Gan & Lee Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂